RX Stock Chart





Fundamentals RX

Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends Paid, FY ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Dividends Yield ---
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Cash Ratio, FY ---
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---
jumpers jumpers WATT, D, Long ,
WATT: Speculative WATT entry before CES 2017
439 0 3
WATT, D Long
Speculative WATT entry before CES 2017

We are watching for a good entry point on Energous with the expectation that price will jump to the green range by JAN 5, when WATT will demo wireless power rx/tx in consumer products. Successful product shipment is already being priced in as the chart follows the green range into DEC. We will look to add to our position if price falls into lower blue range in DEC.

Silver-Silver Silver-Silver AMD, W, Long ,
AMD: Breakout + July Line up
162 1 8
AMD, W Long
Breakout + July Line up

Buy the rumor sell the news. We broke out of the wedge

rx rx TASR, D, Long ,
TASR: Long
27 0 0
TASR, D Long

Looks promising, lots of insider buying.

RyanMartin RyanMartin VRX, D, Short ,
VRX: Valeant Pharma: Moving back down
52 0 1
VRX, D Short
Valeant Pharma: Moving back down

VRX may, at first glance, look like the bloodshed is over and is moving to recovery. Not just yet. The daily MACD and StochRSI are inching toward sell indicators (see screenshot) and despite the markets upward movements today (Mon 12/14), VRX's recovery was pretty modest as more shareholders exit as they see the fall incoming. Bottom line: Put options are a ...

Invest3d Invest3d RX, W, Long ,
RX: $RX.V $BIOYF Downtrend ending, with good Q2 ER.
15 0 0
RX, W Long
$RX.V $BIOYF Downtrend ending, with good Q2 ER.

Really good Q2 with some nice growth. If order was not delayed, y/y growth would've been 38% now it's around 17%, but still the order is shipped so it'll have a big impact on Q3. Technically speaking, I think it will bust out of downtrend soon enough with big bid support around 6,30$

bbeast bbeast DAP-U, W, Long ,
DAP-U: XPEL Technologies Growth
53 0 1
DAP-U, W Long
XPEL Technologies Growth

XPEL has been growing at a steady 70% year over year quarterly results for quite some time. I was made aware of it at $1.65 and began acquiring. The company specializes in automotive paint protection films, and has pretty much taken away the market from 3M. The company is following a similar growth pattern to RX.V (Biosyent). I believe a current cup and handle ...

Panzer_4183 Panzer_4183 RNN, D, Long ,
RNN: RNN is it ready to blast off??
247 1 1
RNN, D Long
RNN is it ready to blast off??

Rexahn is one stock to watch. Few drugs in a pipeline plus pending partnership deal, this stock is ready to move up. Before this happens few things need to be cleared out. Weak holders, panic sellers and reverse stock split in the summer. Analyst who cover this stock target 3pps as average target. But longturn if any of its drugs gets on FDA approval list this ...

Ideas Scripts Chart
United States
United Kingdom
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out